🇺🇸 FDA
Patent

US 8927692

Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same

granted A61KA61K2039/53A61K2039/884

Quick answer

US patent 8927692 (Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same) held by Inovio Pharmaceuticals, Inc. expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Inovio Pharmaceuticals, Inc.
Grant date
Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K2039/53, A61K2039/884, A61K39/00, A61K39/0011